210 related articles for article (PubMed ID: 9267692)
1. Plasma levels of parathyroid hormone that induce anabolic effects in bone of ovariectomized rats can be achieved by stimulation of endogenous hormone secretion.
Fox J; Miller MA; Stroup GB; Nemeth EF; Miller SC
Bone; 1997 Aug; 21(2):163-9. PubMed ID: 9267692
[TBL] [Abstract][Full Text] [Related]
2. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
4. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
5. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
[TBL] [Abstract][Full Text] [Related]
6. Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow.
Nishida S; Yamaguchi A; Tanizawa T; Endo N; Mashiba T; Uchiyama Y; Suda T; Yoshiki S; Takahashi HE
Bone; 1994; 15(6):717-23. PubMed ID: 7873302
[TBL] [Abstract][Full Text] [Related]
7. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
Takano Y; Tanizawa T; Mashiba T; Endo N; Nishida S; Takahashi HE
J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340
[TBL] [Abstract][Full Text] [Related]
8. Daily transient decreases in plasma parathyroid hormone levels induced by the calcimimetic NPS R-568 slows the rate of bone loss but does not increase bone mass in ovariectomized rats.
Miller MA; Fox J
Bone; 2000 Oct; 27(4):511-9. PubMed ID: 11033446
[TBL] [Abstract][Full Text] [Related]
9. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
Baumann BD; Wronski TJ
Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
[TBL] [Abstract][Full Text] [Related]
10. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
11. Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin.
DeLuca PP; Dani BA
AAPS PharmSci; 2001; 3(4):E27. PubMed ID: 12049490
[TBL] [Abstract][Full Text] [Related]
12. Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: effects of long-term administration, withdrawal, and readministration.
Kishi T; Hagino H; Kishimoto H; Nagashima H
Bone; 1998 May; 22(5):515-22. PubMed ID: 9600786
[TBL] [Abstract][Full Text] [Related]
13. Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat.
Hodsman AB; Watson PH; Drost D; Holdsworth D; Thornton M; Hock J; Bryant H; Fraher LJ
Bone; 1999 May; 24(5):451-5. PubMed ID: 10321904
[TBL] [Abstract][Full Text] [Related]
14. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
[TBL] [Abstract][Full Text] [Related]
15. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
[TBL] [Abstract][Full Text] [Related]
16. ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans.
John MR; Widler L; Gamse R; Buhl T; Seuwen K; Breitenstein W; Bruin GJ; Belleli R; Klickstein LB; Kneissel M
Bone; 2011 Aug; 49(2):233-41. PubMed ID: 21514409
[TBL] [Abstract][Full Text] [Related]
17. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
[TBL] [Abstract][Full Text] [Related]
18. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.
Hock JM; Gera I; Fonseca J; Raisz LG
Endocrinology; 1988 Jun; 122(6):2899-904. PubMed ID: 3371266
[TBL] [Abstract][Full Text] [Related]
19. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
Wang L; Orhii PB; Banu J; Kalu DN
Mech Ageing Dev; 2001 Jan; 122(1):89-104. PubMed ID: 11163626
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.
Qi H; Li M; Wronski TJ
J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
